Login / Signup

Endopeptidase Cleavage of Anti-Glomerular Basement Membrane Antibodies in vivo in Severe Kidney Disease: An Open-Label Phase 2a Study.

Fredrik UhlinWladimir SzpirtAndreas KronbichlerAnnette BruchfeldInga SoveriLionel RostaingEric DaugasArnaud LionetNassim KamarCédric RafatMarek MyslivečekVladimir TesarAnders FernströmChristian KjellmanCharlotte ElfvingStephen McAdooJohan MölneIngeborg BajemaElisabeth SonessonMårten M Segelmark
Published in: Journal of the American Society of Nephrology : JASN (2022)
EUDRACT 2016-004082-39 https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-001377-28/results.
Keyphrases
  • phase iii
  • study protocol
  • phase ii
  • clinical trial
  • early onset
  • dna binding
  • diabetic nephropathy
  • high glucose
  • randomized controlled trial
  • open label
  • double blind